GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,641.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 1,711.20
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.88m
  • Volume: 326,450
  • Market Cap: £68,018m
  • RiskGrade: 129

Latest ShareCast News

GSK's endometrial cancer drug receives FDA approval

By Iain Gilbert

Date: Wednesday 24 Apr 2024

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

GSK posts promising results from gonorrhoea treatment trial

By Josh White

Date: Wednesday 17 Apr 2024

(Sharecast News) - GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.

GSK meningococcal vaccine accepted by US FDA for review

By Josh White

Date: Tuesday 16 Apr 2024

(Sharecast News) - GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).

GSK unveils promising results from endometrial c... 18-Mar-2024 ShareCast
GSK reports more encouraging trial results for B... 07-Mar-2024 ShareCast
GSK's ViiV upbeat on ultra-long-acting HIV treat... 05-Mar-2024 ShareCast
GSK reaches settlement in another Zantac case 29-Feb-2024 ShareCast
GSK reports positive results from gonorrhoea tre... 26-Feb-2024 ShareCast
GSK's ViiV sees success in latest HIV treatment ... 21-Feb-2024 ShareCast
Berenberg hikes target price on GSK 15-Feb-2024 ShareCast
London close: Stocks fall as US inflation tops e... 13-Feb-2024 ShareCast
London close: Stocks fall as US inflation tops e... 13-Feb-2024 ShareCast
Citi ups recommendation on GSK to 'buy' 13-Feb-2024 ShareCast
London close: Stocks finish higher after very qu... 12-Feb-2024 ShareCast
GSK gets FDA fast track for chronic hepatitis B ... 12-Feb-2024 ShareCast
GSK reports positive myeloma trial results, prog... 06-Feb-2024 ShareCast
GSK settles Zantac case in California without ad... 01-Feb-2024 ShareCast
London close: Stocks mixed ahead of US Fed, BoE ... 31-Jan-2024 ShareCast
GSK gets EU approval to sell blood cancer treatm... 29-Jan-2024 ShareCast
Citi hikes target price for GSK but stays 'neutr... 26-Jan-2024 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,641.00p
Change Today 5.00p
% Change 0.31 %
52 Week High 1,711.20
52 Week Low 1,316.00
Volume 326,450
Shares Issued 4,144.88m
Market Cap £68,018m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
80.47% below the market average80.47% below the market average80.47% below the market average80.47% below the market average80.47% below the market average
81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average
Price Trend
29.70% above the market average29.70% above the market average29.70% above the market average29.70% above the market average29.70% above the market average
71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average
Income
44.11% above the market average44.11% above the market average44.11% above the market average44.11% above the market average44.11% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
24.54% below the market average24.54% below the market average24.54% below the market average24.54% below the market average24.54% below the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 22-Feb-24 16-Nov-23
Paid 11-Apr-24 11-Jan-24
Amount 16.00p 14.00p

Trades for 25-Apr-2024

Time Volume / Share Price
08:36 371 @ 1,641.00p
08:36 44 @ 1,641.00p
08:36 231 @ 1,641.00p
08:36 48 @ 1,641.00p
08:36 470 @ 1,641.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page